Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/01/2000 | EP0982400A1 Human glycine transporter |
03/01/2000 | EP0982398A1 Substrates for beta-lactamase and uses thereof |
03/01/2000 | EP0981953A2 Transgenic plants transformed with fumonisin detoxifying enzymes |
03/01/2000 | EP0981745A1 The use of a bone morphogenetic protein (bmp) receptor complex for screening |
03/01/2000 | EP0981642A1 Kappa b kinase, subunits thereof, and methods of using same |
03/01/2000 | EP0981637A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
03/01/2000 | EP0981636A1 Lentivirus-based gene transfer vectors |
03/01/2000 | EP0981635A1 Production of mature proteins in plants |
03/01/2000 | EP0981633A2 Hybrid molecules for optically detecting changes in cellular microenvironments |
03/01/2000 | EP0981631A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
03/01/2000 | EP0981630A1 Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same |
03/01/2000 | EP0981629A1 Forms of prostate specific antigen and methods for their detection |
03/01/2000 | EP0981627A1 Purified telomerase |
03/01/2000 | EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
03/01/2000 | EP0981623A1 Gene encoding for systemic acquired resistance in arabidopsis |
03/01/2000 | EP0981621A1 Plant gene constructs and their use |
03/01/2000 | EP0981620A1 Hgf polypeptides and their use in therapy |
03/01/2000 | EP0981619A1 T1/st2-receptor ligand iii |
03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
03/01/2000 | EP0981617A1 Recombinant lactoferrin, methods of production from plants and uses |
03/01/2000 | EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2) |
03/01/2000 | EP0981612A2 Secreted proteins and polynucleotides encoding them |
03/01/2000 | EP0981604A1 Targeted gene modification by parvoviral vectors |
03/01/2000 | EP0981603A1 Models for haematopoiesis |
03/01/2000 | EP0981602A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
03/01/2000 | EP0981601A1 Methods for cultivating cells and propagating viruses |
03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
03/01/2000 | EP0981547A1 Tumor-associated antigen |
03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
03/01/2000 | EP0981537A1 An infectious clone for human parainfluenza virus type 3 |
03/01/2000 | EP0981381A2 POLYHYDROXYALKANOATES FOR $i(IN VIVO) APPLICATIONS |
03/01/2000 | EP0891419A4 Hematopoietic cell culture nutrient supplement |
03/01/2000 | EP0821592A4 Compositions and methods for regulating hair growth |
03/01/2000 | EP0804230B1 Vaccine against mycobacterial infections |
03/01/2000 | CN1246151A Mutants of streptococcal toxin A and methods of use |
02/29/2000 | US6031151 Callus-specific promoters |
02/29/2000 | US6031150 Genome with homozygous disruption of gene by selectable marker; for studying non-insulin dependent diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy |
02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
02/29/2000 | US6031079 Amino acid sequence; for screening modulators |
02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
02/29/2000 | US6031072 Compounds and methods for modulating cell adhesion |
02/29/2000 | US6030945 Apo-2 ligand |
02/29/2000 | US6030836 Concurrent culturing of human mesenchymal stem cells with hematopoietic stem cells to retain stem cell phenotype |
02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
02/29/2000 | US6030832 Dna sequence of protein which interacts with domain of tumor suppressor protein |
02/29/2000 | US6030831 Tie ligand homologues |
02/29/2000 | US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
02/29/2000 | US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents |
02/29/2000 | US6030794 Determining subtype or isoform bound by agent by incubating agent with one or more cell lines homozygous for a disruption in one or more of its receptor genes, determining the amount of agent, and comparing to control cells |
02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
02/29/2000 | US6030792 Quantitative immunoassay using capture and detection antibodies against specific amino acid sequences of collagen fragments resulting from collagenase cleavage of type ii collagen |
02/29/2000 | US6030789 Culturing human conjunctival epithelial cells in serum-free medium, then transfecting with vector; cells retain stratification and transepithelial barrier function; for in vitro screening using three-dimensional cultures |
02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
02/29/2000 | US6030625 Bordetella pertussis and Bordetella parapertussis strains |
02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
02/29/2000 | CA1340915C Myeloperoxydase humaine et application therapeutique |
02/28/2000 | CA2281442A1 Use of a cationic polymer for the preparation of a complex with nucleic acid and related compositions |
02/28/2000 | CA2249037A1 Novel compounds |
02/24/2000 | WO2000010009A1 Agarose format for mammalian cell based reporter assays |
02/24/2000 | WO2000009727A2 Dna shuffling to produce herbicide selective crops |
02/24/2000 | WO2000009721A1 Increasing stearate content in soybean oil by expression of acyl-acp thiosterase |
02/24/2000 | WO2000009719A1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors |
02/24/2000 | WO2000009717A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
02/24/2000 | WO2000009716A1 Method for purifying proteins and/or biomolecule or protein complexes |
02/24/2000 | WO2000009714A1 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
02/24/2000 | WO2000009712A1 Transcription factors regulating the expression of ethylene-inducible genes |
02/24/2000 | WO2000009709A2 Proteases and associated proteins |
02/24/2000 | WO2000009708A1 Dna constructs comprising protease encoding sequences or inhibitors thereof |
02/24/2000 | WO2000009706A2 Maize cellulose synthases and uses thereof |
02/24/2000 | WO2000009704A1 Gene switch |
02/24/2000 | WO2000009700A1 Rna virus vector having contact infiltration capability |
02/24/2000 | WO2000009697A2 Pesticidal toxins and genes from bacillus laterosporus strains |
02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
02/24/2000 | WO2000009689A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
02/24/2000 | WO2000009686A1 Gene |
02/24/2000 | WO2000009682A1 Dna shuffling of monooxygenase genes for production of industrial chemicals |
02/24/2000 | WO2000009679A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
02/24/2000 | WO2000009674A1 Mammalian transgenesis by intracytoplasmic sperm injection |
02/24/2000 | WO2000009669A1 Human mesencephalon cell lines and methods of use therefor |
02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
02/24/2000 | WO2000009667A1 Calcineurin-dependent control of skeletal muscle fiber type |
02/24/2000 | WO2000009666A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
02/24/2000 | WO2000009658A2 Gene regulating circadian clock function and photoperiodism |
02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
02/24/2000 | WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them |
02/24/2000 | WO2000009550A1 Vanadate resistance glycosylation 4 gene |
02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
02/24/2000 | WO2000009541A1 nrdE |
02/24/2000 | WO2000009538A2 Canine growth hormone secretagogue receptor |
02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |